Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/64803/000006480323000009/cvs-20221231.htm
May 2024
May 2024
May 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
October 2023
Date of Report (Date of earliest event reported): |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Emerging growth company | |||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/64803/000006480323000009/cvs-20221231.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Cvs Health Corp.
Cvs Health Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Cvs Health Corp provided additional information to their SEC Filing as exhibits
Ticker: CVS
CIK: 64803
Form Type: 10-K Annual Report
Accession Number: 0000064803-23-000009
Submitted to the SEC: Wed Feb 08 2023 6:37:38 AM EST
Accepted by the SEC: Wed Feb 08 2023
Period: Saturday, December 31, 2022
Industry: Retail Drug Stores And Proprietary Stores